GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7EFP | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y) | |
7K9H | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) | |
7SY8 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7V76 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation | |
7FJC | P0DTC2 | Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab | |
7U0P | P0DTC2 | SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 | |
7UPL | P0DTC2 | SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 | |
7UPW | P0DTC2 | Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment | |
7UPX | P0DTC2 | Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) | |
7UPY | P0DTC2 | An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion | |
7V20 | P0DTC2 | CryoEM structure of del68-76/del679-688 prefusion-stabilized spike | |
7V23 | P0DTC2 | CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9 | |
7V27 | P0DTC2 | RBD/XG005 local refinement | |
7VOA | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with aRBD5 | |
7WCD | P0DTC2 | Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4 | |
7RU1 | P0DTC2 | SARS-CoV-2-6P-Mut7 S protein (C3 symmetry) | |
7RU2 | P0DTC2 | SARS-CoV-2-6P-Mut7 S protein (asymmetric) | |
7RU3 | P0DTC2 | CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement) | |
7RU4 | P0DTC2 | CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement) | |
7RU5 | P0DTC2 | CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement) | |
7RU8 | P0DTC2 | CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement) | |
7T3M | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map | |
7T67 | P0DTC2 | SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up | |
7YDI | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region | |
7YDY | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab | |
7YE5 | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs | |
7YE9 | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs | |
7YEG | P0DTC2 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 | |
8DAD | P0DTC2 | SARS-CoV-2 receptor binding domain in complex with AZ090 Fab | |
8DI5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6) | |
8DLI | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein | |
8DLN | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLS | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8) | |
8DLT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein | |
8DLU | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 | |
8DLV | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLW | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 | |
8DLX | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 | |
8DLY | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DLZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 | |
8DM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6) | |
8DZH | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
8DZI | P0DTC2 | Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02 | |
7XRP | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) | |
8BSE | P0DTC2 | CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD) in complex with 1D1 Fab | |
8BSF | P0DTC2 | CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD-beta variant) in complex with 3D2 Fab | |
8CSJ | P0DTC2 | Cryo-EM structure of NTD-directed non-neutralizing antibody 4-33 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
8HN7 | P0DTC2 | Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD | |
8IF2 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
7WT7 | P0DTC2 | SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 1) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024